Phase Space Research

Groupon

GRPN · Investment summary · as of 3 August 2026

Priced slightly ahead of what the business has demonstrated

Portfolio decision
No position
Price · 3 August 2026
$27.65
12-month target
$28.00 +1%
Expected return
+1.3%
Next decision point
Date not announced

Business type: Declining · scaling but economically observable

The business does not meet the quality standard for its economic type.

Investment view

At $27.65, GRPN requires a 13% five-year revenue growth rate to justify its enterprise value — more than the business has ever demonstrated, at -6%.

The value rests on an exit multiple of 8.3x, a terminal operating margin of 18% and a 9.9% cost of capital. Move any one of them materially and the conclusion moves with it, which is why the required-versus-demonstrated test above carries more weight here than the point value.

The strongest argument against this view: AI-answer-engine disintermediation of local discovery: organic/SEO + email acquisition decays faster than the AI-native rebuild replaces it (mechanism already visible - management named managed and organic channels as Q1'26 headwinds) while the 15% headcount cut removes execution capacity; revenue re-enters -5-10%/yr decline, adj-EBITDA margin reverts to ~10%, multiple to the 5.7x floor.

Underwriting bridge

QuestionEvidence-based conclusion
What drives the business?Filed FY24/FY25 statements + quantified FY26 guidance + board-approved restructuring economics (8-K 21 May 2026: $20-25M annualized saves, $7-13M charges).
What do we forecast?Revenue growth of -6% demonstrated; a terminal operating margin of 18%; an exit multiple of 8.3x.
What does Street forecast?Not determined — no consensus estimates are joined to this record
Where do we differ?On terminal margin, the difference between what the price requires and what the business has demonstrated is -14.0 percentage points.
What is it worth?Twelve-month target $28.00, +1% from the struck price. Scenario-weighted expected return net of costs +1.3%.
Why now?Date not announced — no dated event that would resolve the disagreement is on file

What must go right

  1. By Date not announced — no test date is stated for this conditionThe condition does not occur: FY26 FX-neutral billings growth < +1% (guide +3-5%) - tested at the FY26 print (2027-03)Where it stands: Not determined — no current reading of this metric is on file
  2. By Date not announced — no test date is stated for this conditionThe condition does not occur: H2'26 adjusted EBITDA < $44M vs guide-implied >=$50.7M (15% grace) - tested 2026-11 and 2027-03Where it stands: Not determined — no current reading of this metric is on file
  3. By Date not announced — no test date is stated for this conditionThe condition does not occur: Active customers decline YoY in any quarter through FY27 - tested quarterlyWhere it stands: Not determined — no current reading of this metric is on file

Catalysts and falsifiers

Date not announced — no dated event that would resolve the disagreement is on file

Risk and sell discipline

Impairment case

AI-answer-engine disintermediation of local discovery: organic/SEO + email acquisition decays faster than the AI-native rebuild replaces it (mechanism already visible - management named managed and organic channels as Q1'26 headwinds) while the 15% headcount cut removes execution capacity; revenue re-enters -5-10%/yr decline, adj-EBITDA margin reverts to ~10%, multiple to the 5.7x floor.

Estimated probability 25%, against the 12% level at which the position would be resized. It sits above that level, so this case could not be carried at full size.

Fundamental invalidation

Falsifiable and fundamental — not one of them is a price condition.

Price-based risk trigger

A daily close below $21.66 triggers an immediate review of the thesis and pauses additional buying. It is not an automatic sell unless a separate fundamental invalidation condition has been breached.

Upside sell discipline

Trim/exit when forward E[R] < 0 at the 1y-average anchor: mechanically, price > ~12.5x NTM adj-EBITDA without an accompanying estimate raise (~$33-34 on current numbers). On approach to the $28.00 target the case is reviewed rather than added to; a target reached is a reason to re-examine the position, not to hold it by default. The position is trimmed once forward expected return falls below 0% net of costs, because the capital has a better use elsewhere in the book.

Investment criteria

CriteriaStatusInvestment meaning
QualityNot metIs the business worth owning under its declared economic type?
ValuationNot metIs the operating path required by today's price achievable?
LiquidityMetCan the intended position be built and exited in the right vehicle?
DownsideMetAI-answer-engine disintermediation of local discovery: organic/SEO + email acquisition decays faster than the AI-native rebuild replaces it (mechanism already visible - management named managed and organic channels as Q1'26 headwinds) while the 15% headcount cut removes execution capacity; revenue re-enters -5-10%/yr decline, adj-EBITDA margin reverts to ~10%, multiple to the 5.7x floor.
MomentumNot determinedDoes price action support or complicate entry timing? Not established on the evidence on file.
CatalystNot determinedIs there a dated event that resolves the disagreement? Not established on the evidence on file.
ConsensusNot determinedIs the house-versus-Street disagreement identified and quantified? Not established on the evidence on file.

Quality, valuation and liquidity can prevent a position on their own. The remaining four inform timing, sizing and monitoring, and never reject an investment by themselves.

Bottom line

The gap between what today's price requires and what the business has demonstrated is -14.0 percentage points, and that gap — not the multiple — is the case that the security is mispriced. The most important unresolved uncertainty is the permanent-loss mechanism: AI-answer-engine disintermediation of local discovery: organic/SEO + email acquisition decays faster than the AI-native rebuild replaces it (mechanism already visible - management named managed and organic channels as Q1'26 headwinds) while the 15% headcount cut removes execution capacity; revenue re-enters -5-10%/yr decline, adj-EBITDA margin reverts to ~10%, multiple to the 5.7x floor. The next evidence that should change the portfolio decision is the next scheduled results, or a daily close below $21.66, which forces an immediate review.